8-K//Current report
CRISPR Therapeutics AG 8-K
Accession 0000950170-24-067660
$CRSPCIK 0001674416operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 8:06 AM ET
Size
931.4 KB
Accession
0000950170-24-067660
Documents
- 8-Kcrsp-20240530.htmPrimary
8-K
- EX-3.1crsp-ex3_1.htm
EX-3.1
- EX-101.SCHcrsp-20240530.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-24-067660-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLcrsp-20240530_htm.xml
IDEA: XBRL DOCUMENT
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeoperating
IncorporatedSwitzerland
Related Parties
1- filerCIK 0001674416
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 8:06 AM ET
- Size
- 931.4 KB